medigraphic.com
ISSN 1561-2937 (Impreso)

2014, Número 3

<< Anterior Siguiente >>

Rev Cubana Cardiol Cir Cardiovasc 2014; 20 (3)


Síndrome de Brugada en una mujer con presíncopes recurrentes. Reporte de caso

Romero GAR, Castro HJ, Domínguez-Peréz RJ, Santos HA, Ricardo IE, Arias-Salazar W

Idioma: Español
Referencias bibliográficas: 10
Paginas: 158-165
Archivo PDF: 1712.53 Kb.


RESUMEN

Presentamos el caso de una mujer joven atendida por episodios presincopales recurrentes, con electrocardiogramas iniciales normales, patrón de Brugada Tipo I oculto o intermitente, test de procainamida positivo y estudio electrofisiológico negativo, a la cual se le implantó un cardioversor desfibrilador automático implantable.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am CollCardiol. 1992; 20:1391-6.

  2. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, et al. Brugada Syndrome: Report of the Second Consensus Conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005;111:659-70.

  3. Miyasaka Y, Tsuji H, Yamada K, Tokunaga S, Saito D, Imuro Y, et al. Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan. J Am CollCardiol. 2001; 38:771-4.

  4. Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation. 2002; 105:73-8.

  5. Benito B, Sarkosy A, Mont L, Henkens S, Berrueso A, Tamborero D, et al. Gender differences in clinical manifestations of Brugada syndrome. J Am CollCardiol. 2008; 52:1567-73.

  6. Veltmann C, Schimpf R, Echternach C, Eckardt L, Kuschyk J, Streitner F, et al. A prospective study of spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification. EurHeart J. 2006;27:2544-52.

  7. CastroJ, Antzelevitch C, Tornés F, Dorantes M, Dorticós F, Zayas R, et al. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia /ventricular fibrillation in patients with the Brugada syndrome. J Am CollCardiol. 2006;47:1828-34.

  8. BabaiBigi MA, Aslani A, Shahrzad S. aVR sign as a risk factor for life-threatening arrhythmic events in patients with Brugada syndrome. HeartRhythm. 2007;4:1009-12.

  9. Tada T, Kusano KF, Negase S, Banba K, Miura D, Nishii N, et al. Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome J Cardiovasc Electrophysiol. 2008;19:5661.

  10. Kusano KF, Taniyama M, Nakamura K, Miura D, Banba K, Nagase S, et al. Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds. J Am CollCardiol. 2008; 51:1169-75.




2020     |     www.medigraphic.com